Hormone replacement therapy and stroke risk in older women

Journal of Women's Health

Volumn 8, Issue 3, 1999, Pages 359-364

  Fung, Maple M ^a   Barrett Connor, Elizabeth ^b   Bettencourt, Richele R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; COHORT ANALYSIS; DEATH CERTIFICATE; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; RISK FACTOR; STATISTICS; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

EID: 0032955799     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1999.8.359     Document Type: Article

References (25)

1. Grady D, Rubin SM, Petitti DB, et al. Hormone replacement therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016.
2. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 1995;38:223.
3. U.S. Bureau of the Census, Statistical Abstract of the U.S., 116th ed. Washington, DC: 1996.
4. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971.
5. Boysen G, Nyboe J, Appleyard M, et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988;19:1345.
6. Bush T, Barrett-Connor E, Cowan L, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program follow-up study. Circulation 1987;75:1102.
7. Cauley JA, Seeley DG, Browner WS, et al. Estrogen replacement therapy and mortality among older women. Arch Intern Med 1997;157:2181.
8. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among post-menopausal hormone users. Arch Intern Med 1993; 153:73.
9. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75.
10. Lindenstrom E, Boysen G, Nyboe J. Lifestyle factors and risk of cerebrovascular disease in women. Stroke 1993;24:1468.
11. Paganini-Hill A, Ross RK, Henderson BE. Post-menopausal oestrogen treatment and stroke: A prospective study. Br Med J 1988;297:519.
12. Schairer C, Adami HO, Hoover R, Persson I. Cause-specific mortality in women receiving hormone replacement therapy. Epidemiology 1997;8:59.
13. Wilson PW, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med 1985;313:1038.
14. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull WHO 1962;27:645.
15. Hypertension Detection and Follow-Up Prevention Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med 1976;5:207.
16. Lipid Research Clinics Epidemiology Committee. Plasma lipid distributions in selected North American populations: The LRC prevalence study. Circulation 1979;60:427.
17. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 1972;18:499.
18. Engelglau MM, Thompson TJ, Herman WH, et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diabetes Care 1997;20: 785.
19. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: A classification system. Circulation 1998;21:1160.
20. Public Health Service and Health Care Financing Administration. International classification of diseases, 9th revision. Clinical modification. Washington, DC: Public Health Service, 1980.
21. SAS user's guide, version 6, 4th ed. Cary, NC: SAS Institute Inc, 1989.
22. Barrett-Connor E, Brown WV, Turner J, Austin M, Criqui MH. Heart disease risk factors and hormone use in post-menopausal women. JAMA 1979;241: 2167.
23. Pederson AT, Lidegaard O, Kreiner S, Ottesen B. Hormone replacement therapy and the risk of non-fatal stroke. Lancet 1997;350:1277.
24. Petitti DB, Sidney S, Quesenberry CP, Bernstein A. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23.
25. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55.